Adalimumab vs Ipilimumab

## Adalimumab vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Ipilimumab**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Ipilimumab — 14.7 days.

## Chemical Properties

**Type**: Adalimumab — Antibody; Ipilimumab — Antibody.